These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1120188)

  • 1. Some factors affecting fibrinogen precipitation by ristocetin: ultrastructure of precipitates.
    Ts'ao C; Green D; Rossi EC
    Blood; 1975 May; 45(5):621-9. PubMed ID: 1120188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Function and ultrastructure of platelets of neonates: enhanced ristocetin aggregation of neonatal platelets.
    Ts'ao CH; Green D; Schultz K
    Br J Haematol; 1976 Feb; 32(2):225-33. PubMed ID: 1247495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ristocetin induces platelet aggregation: a morphological demonstration.
    Escolar G; Monteagudo J; Villamor N; Garrido M; Castillo R; Ordinas A
    Br J Haematol; 1988 Jul; 69(3):379-86. PubMed ID: 3136792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of receptors for fibrinogen and von Willebrand factor mediating aggregation in guinea pig platelets.
    Kupinski JM; Miller JL
    Thromb Res; 1986 Aug; 43(3):335-44. PubMed ID: 3016944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ristocetin- and thrombin-induced platelet aggregation at physiological shear rates: differential roles for GPIb and GPIIb-IIIa receptor.
    Kasirer-Friede A; Frojmovic MM
    Thromb Haemost; 1998 Sep; 80(3):428-36. PubMed ID: 9759623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunocytochemical localization of fibrinogen during thrombin-induced aggregation of washed human platelets.
    Suzuki H; Kinlough-Rathbone RL; Packham MA; Tanoue K; Yamazaki H; Mustard JF
    Blood; 1988 May; 71(5):1310-20. PubMed ID: 3359044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. von Willebrand factor. A protein which binds at the cell surface interface between platelets.
    Senogles SE; Nelsestuen GL
    J Biol Chem; 1983 Oct; 258(20):12327-33. PubMed ID: 6605342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of thrombin and ristocetin in the interaction between von Willebrand factor and platelets.
    Harrison RL; McKee PA
    Blood; 1983 Aug; 62(2):346-53. PubMed ID: 6307433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of cathepsin G pretreatment of platelets on their subsequent responses to aggregating agents.
    Kinlough-Rathbone RL; Perry DW; Rand ML; Packham MA
    Thromb Res; 1999 Sep; 95(6):315-23. PubMed ID: 10527409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unexpected effects of aurin tricarboxylic acid on human platelets.
    Kinlough-Rathbone RL; Packham MA
    Thromb Haemost; 1992 Aug; 68(2):189-93. PubMed ID: 1412166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adhesion of platelets to purified solid-phase von Willebrand factor: effects of wall shear rate, ADP, thrombin, and ristocetin.
    Olson JD; Zaleski A; Herrmann D; Flood PA
    J Lab Clin Med; 1989 Jul; 114(1):6-18. PubMed ID: 2786916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new von Willebrand variant (type I, New York): increased ristocetin-induced platelet aggregation and plasma von Willebrand factor containing the full range of multimers.
    Weiss HJ; Sussman II
    Blood; 1986 Jul; 68(1):149-56. PubMed ID: 3487353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A monoclonal antibody directed against a granule membrane glycoprotein (GMP-140/PADGEM, P-selectin, CD62P) inhibits ristocetin-induced platelet aggregation.
    Boukerche H; Ruchaud-Sparagano MH; Rouen C; Brochier J; Kaplan C; McGregor JL
    Br J Haematol; 1996 Feb; 92(2):442-51. PubMed ID: 8603015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of Haemaccel, fibrinogen and albumin on ristocetin-induced platelet aggregation. Relevance to the quantitative measurement of the ristocetin cofactor.
    Stibbe J; Kirby EP
    Thromb Res; 1976 Feb; 8(2):151-65. PubMed ID: 1251347
    [No Abstract]   [Full Text] [Related]  

  • 15. Interactions of purified rat factor VIII/von Willebrand factor with rat and human platelets--effect of albumin and ristocetin.
    Dejana E; Furlan M; Barbieri B; Donati MB; Beck EA
    Thromb Haemost; 1984 Aug; 52(1):57-9. PubMed ID: 6437011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alterations of blood platelet function induced by neutral proteases from human leukocytes.
    Bykowska K; Kaczanowska J; Karpowicz M; Lopaciuk S; Kopeć M
    Thromb Res; 1985 Jun; 38(5):535-46. PubMed ID: 3892761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on the mechanism of ristocetin-induced platelet aggregation.
    Kattlove HE; Gomez MH
    Blood; 1975 Jan; 45(1):91-6. PubMed ID: 803115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dimeric ristocetin flocculates proteins, binds to platelets, and mediates von Willebrand factor-dependent agglutination of platelets.
    Scott JP; Montgomery RR; Retzinger GS
    J Biol Chem; 1991 May; 266(13):8149-55. PubMed ID: 2022635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Qualitative description of factors involved in the retraction and lysis of dilute whole blood clots and in the aggregation and retraction of platelets.
    Taylor FB; Müller-Eberhard HJ
    J Clin Invest; 1970 Nov; 49(11):2068-85. PubMed ID: 4248913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of ADP and ATP on bovine fibrinogen- and ristocetin-induced platelet aggregation in Glanzmann's thrombasthenia.
    Cohen I; Glaser T; Seligsohn U
    Br J Haematol; 1975 Nov; 31(3):343-7. PubMed ID: 1201247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.